mesenchymal stromal cells
/ Educell
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 29, 2021
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment.
(PubMed, Pharmaceutics)
- "Therefore, the use of MSCs in COVID-19-induced respiratory failure and ARDS was a logical step in order to find a potential treatment option for the most severe patients. In this review, the main characteristics of MSCs, their proposed mechanism of action in COVID-19 treatment and the effect of this therapy in published case reports and clinical trials are discussed."
Journal • Review • Acute Respiratory Distress Syndrome • Immune Modulation • Immunology • Infectious Disease • Inflammation • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
April 21, 2021
Intracellular delivery of trehalose renders mesenchymal stromal cells viable and immunomodulatory competent after cryopreservation.
(PubMed, Cytotechnology)
- "Highest expression was seen for the IDO1 and TSG6 genes. In conclusion, cryopreservation of mesenchymal stromal cells in trehalose results in comparable characteristics to their cryopreservation using dimethyl sulfoxide."
IO biomarker • Journal • Immune Modulation • Immunology • Inflammation • IDO1
1 to 2
Of
2
Go to page
1